Targeting IGF Perturbs Global Replication through Ribonucleotide Reductase Dysfunction
- PMID: 33509941
- DOI: 10.1158/0008-5472.CAN-20-2860
Targeting IGF Perturbs Global Replication through Ribonucleotide Reductase Dysfunction
Abstract
Inhibition of IGF receptor (IGF1R) delays repair of radiation-induced DNA double-strand breaks (DSB), prompting us to investigate whether IGF1R influences endogenous DNA damage. Here we demonstrate that IGF1R inhibition generates endogenous DNA lesions protected by 53BP1 bodies, indicating under-replicated DNA. In cancer cells, inhibition or depletion of IGF1R delayed replication fork progression accompanied by activation of ATR-CHK1 signaling and the intra-S-phase checkpoint. This phenotype reflected unanticipated regulation of global replication by IGF1 mediated via AKT, MEK/ERK, and JUN to influence expression of ribonucleotide reductase (RNR) subunit RRM2. Consequently, inhibition or depletion of IGF1R downregulated RRM2, compromising RNR function and perturbing dNTP supply. The resulting delay in fork progression and hallmarks of replication stress were rescued by RRM2 overexpression, confirming RRM2 as the critical factor through which IGF1 regulates replication. Suspecting existence of a backup pathway protecting from toxic sequelae of replication stress, targeted compound screens in breast cancer cells identified synergy between IGF inhibition and ATM loss. Reciprocal screens of ATM-proficient/deficient fibroblasts identified an IGF1R inhibitor as the top hit. IGF inhibition selectively compromised growth of ATM-null cells and spheroids and caused regression of ATM-null xenografts. This synthetic-lethal effect reflected conversion of single-stranded lesions in IGF-inhibited cells into toxic DSBs upon ATM inhibition. Overall, these data implicate IGF1R in alleviating replication stress, and the reciprocal IGF:ATM codependence we identify provides an approach to exploit this effect in ATM-deficient cancers. SIGNIFICANCE: This study identifies regulation of ribonucleotide reductase function and dNTP supply by IGFs and demonstrates that IGF axis blockade induces replication stress and reciprocal codependence on ATM. GRAPHICAL ABSTRACT: http://cancerres.aacrjournals.org/content/canres/81/8/2128/F1.large.jpg.
©2021 American Association for Cancer Research.
Similar articles
-
Implication of checkpoint kinase-dependent up-regulation of ribonucleotide reductase R2 in DNA damage response.J Biol Chem. 2009 Jul 3;284(27):18085-95. doi: 10.1074/jbc.M109.003020. Epub 2009 May 5. J Biol Chem. 2009. PMID: 19416980 Free PMC article.
-
Inhibition of the ATR-CHK1 Pathway in Ewing Sarcoma Cells Causes DNA Damage and Apoptosis via the CDK2-Mediated Degradation of RRM2.Mol Cancer Res. 2020 Jan;18(1):91-104. doi: 10.1158/1541-7786.MCR-19-0585. Epub 2019 Oct 24. Mol Cancer Res. 2020. PMID: 31649026 Free PMC article.
-
CHK1 inhibition exacerbates replication stress induced by IGF blockade.Oncogene. 2022 Jan;41(4):476-488. doi: 10.1038/s41388-021-02080-1. Epub 2021 Nov 12. Oncogene. 2022. PMID: 34773074 Free PMC article.
-
The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer.Adv Cancer Res. 2010;108:73-112. doi: 10.1016/B978-0-12-380888-2.00003-0. Adv Cancer Res. 2010. PMID: 21034966 Review.
-
Roles of ATM and ATR in DNA double strand breaks and replication stress.Prog Biophys Mol Biol. 2021 May;161:27-38. doi: 10.1016/j.pbiomolbio.2020.11.005. Epub 2020 Nov 28. Prog Biophys Mol Biol. 2021. PMID: 33259832 Review.
Cited by
-
Emerging Role of IGF-1 in Prostate Cancer: A Promising Biomarker and Therapeutic Target.Cancers (Basel). 2023 Feb 17;15(4):1287. doi: 10.3390/cancers15041287. Cancers (Basel). 2023. PMID: 36831629 Free PMC article. Review.
-
The key cellular senescence related molecule RRM2 regulates prostate cancer progression and resistance to docetaxel treatment.Cell Biosci. 2023 Nov 15;13(1):211. doi: 10.1186/s13578-023-01157-6. Cell Biosci. 2023. PMID: 37968699 Free PMC article.
-
WNT5A-ROR2 axis mediates VEGF dependence of BRAF mutant melanoma.Cell Oncol (Dordr). 2023 Apr;46(2):391-407. doi: 10.1007/s13402-022-00757-7. Epub 2022 Dec 21. Cell Oncol (Dordr). 2023. PMID: 36539575 Free PMC article.
-
Preclinical validation and phase I trial of 4-hydroxysalicylanilide, targeting ribonucleotide reductase mediated dNTP synthesis in multiple myeloma.J Biomed Sci. 2022 May 12;29(1):32. doi: 10.1186/s12929-022-00813-2. J Biomed Sci. 2022. PMID: 35546402 Free PMC article. Clinical Trial.
-
Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition.Clin Cancer Res. 2023 Jan 17;29(2):458-471. doi: 10.1158/1078-0432.CCR-22-2587. Clin Cancer Res. 2023. PMID: 36394520 Free PMC article.
References
-
- Simpson A, Petnga W, Macaulay VM, Weyer-Czernilofsky U, Bogenrieder T. Insulin-Like Growth Factor (IGF) pathway targeting in cancer: role of the IGF axis and opportunities for future combination studies. Target Oncol. 2017;12:571–97.
-
- Valentinis B, Baserga R. IGF-I receptor signalling in transformation and differentiation. Mol Pathol. 2001;54:133–7.
-
- Turner BC, Haffty BG, Narayanan L, Yuan J, Havre PA, Gumbs AA, et al. Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation. Cancer Res. 1997;57:3079–83.
-
- Aleksic T, Verrill C, Bryant RJ, Han C, Worrall AR, Brureau L, et al. IGF-1R associates with adverse outcomes after radical radiotherapy for prostate cancer. Br J Cancer. 2017;117:1600–6.
-
- Macaulay VM, Salisbury AJ, Bohula EA, Playford MP, Smorodinsky NI, Shiloh Y. Downregulation of the type 1 insulin-like growth factor receptor in mouse melanoma cells is associated with enhanced radiosensitivity and impaired activation of Atm kinase. Oncogene. 2001;20:4029–40.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous